title: Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.
abstract: Low to moderate ethanol consumption has been associated with protective effects in autoimmune diseases such as rheumatoid arthritis, RA. An expansion of γδ T cells induced by isopentenyl pyrophosphate, IPP, likewise seems to have a protective role in arthritis. The aim of this project was to test the hypothesis that low doses of ethanol can enhance IPP-induced expansion of synovial fluid γδ T cells from patients with arthritis and may thereby potentially account for the beneficial effects of ethanol on symptoms of the arthritic process. Thus, mononuclear cells from synovial fluid (SF) from 15 patients with arthritis and from peripheral blood (PB) from 15 healthy donors were stimulated with low concentrations of ethanol and IPP for 7 days in vitro. IPP in combination with ethanol 0.015%, 2.5 mM, equivalent to the decrease per hour in blood ethanol concentration due to metabolism, gave a significantly higher fractional expansion of SF γδ T cells compared with IPP alone after 7 days (ratio 10.1+/-4.0, p<0.0008, n = 12) in patients with arthritis. Similar results were obtained for PB γδ T cells from healthy controls (ratio 2.0+/-0.4, p<0.011, n = 15). The augmented expansion of γδ T cells in SF is explained by a higher proliferation (p = 0.0034, n = 11) and an increased survival (p<0.005, n = 11) in SF cultures stimulated with IPP plus ethanol compared to IPP alone. The synergistic effects of IPP and ethanol indicate a possible allosteric effect of ethanol. Similar effects could be seen when stimulating PB with ethanol in presence of risedronate, which has the ability to increase endogenous levels of IPP. We conclude that expansion of γδ T cells by combinatorial drug effects, possibly in fixed-dose combination, FDC, of ethanol in the presence of IPP might give a protective role in diseases such as arthritis.
authors.affiliation: Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Agneta J
authors.initials: AJ
authors.lastname: Laurent
authors.affiliation: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: Niels
authors.initials: N
authors.lastname: Bindslev
authors.affiliation: Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Björn
authors.initials: B
authors.lastname: Johansson
authors.affiliation: Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Louise
authors.initials: L
authors.lastname: Berg
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004357:Drug Synergism; D000431:Ethanol / Q000494:pharmacology*; D012968:Etidronic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D045782:Hemiterpenes / Q000494:pharmacology*; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D010641:Phenotype; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000378:metabolism; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism*; D000068296:Risedronic Acid; D013582:Synovial Fluid / Q000166:cytology* / Q000187:drug effects / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000187:drug effects*
chemical_list: D045782:Hemiterpenes; D009943:Organophosphorus Compounds; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016692:Receptors, Antigen, T-Cell, gamma-delta; C004809:isopentenyl pyrophosphate; D000431:Ethanol; D007371:Interferon-gamma; D000068296:Risedronic Acid; D012968:Etidronic Acid
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8175-9
references.pmid: 8058775
references.citation: Anal Biochem. 1997 Oct 1;252(1):89-95
references.pmid: 9324945
references.citation: Immunology. 1997 Aug;91(4):503-10
references.pmid: 9378487
references.citation: Rheumatology (Oxford). 2013 May;52(5):856-67
references.pmid: 23287363
references.citation: Immunol Rev. 2008 Jun;223:252-70
references.pmid: 18613841
references.citation: Clin Exp Immunol. 1984 Jul;57(1):123-9
references.pmid: 6611230
references.citation: Clin Exp Immunol. 1992 Sep;89(3):427-33
references.pmid: 1387595
references.citation: Blood. 2004 Sep 15;104(6):1801-7
references.pmid: 15178578
references.citation: Cell Mol Immunol. 2012 May;9(3):245-54
references.pmid: 22139198
references.citation: Ann Rheum Dis. 1975 Oct;35(5):451-5
references.pmid: 1086654
references.citation: PLoS One. 2011 Feb 03;6(2):e16700
references.pmid: 21304898
references.citation: Arthritis Res Ther. 2006;8(4):R133
references.pmid: 16872514
references.citation: J Clin Invest. 1977 Aug;60(2):284-94
references.pmid: 194924
references.citation: Sci Signal. 2008 Jul 15;1(28):re7
references.pmid: 18632551
references.citation: Cell Signal. 2008 Sep;20(9):1592-607
references.pmid: 18423978
references.citation: J Immunol. 1994 Dec 1;153(11):5133-40
references.pmid: 7963571
references.citation: Ann Rheum Dis. 2000 Jan;59(1):75-6
references.pmid: 10627433
references.citation: Nat Rev Rheumatol. 2013 Jan;9(1):24-33
references.pmid: 23147896
references.citation: J Immunol. 2003 May 15;170(10):4963-72
references.pmid: 12734339
references.citation: Rheumatology (Oxford). 2010 Nov;49(11):2140-6
references.pmid: 20667949
references.citation: J Immunol. 2011 Nov 15;187(10):5099-113
references.pmid: 22013129
references.citation: BMC Pharmacol Toxicol. 2013 Jan 08;14:4
references.pmid: 23298758
references.citation: Immunobiology. 2010 May;215(5):380-94
references.pmid: 19589616
references.citation: Epidemiology. 1994 Sep;5(5):525-32
references.pmid: 7986867
references.citation: J Rheumatol. 2002 Feb;29(2):246-54
references.pmid: 11838841
references.citation: Eur J Immunol. 2009 Mar;39(3):752-62
references.pmid: 19197941
references.citation: J Immunol. 2007 Dec 15;179(12):8287-96
references.pmid: 18056373
references.citation: Nature. 1989 May 18;339(6221):226-9
references.pmid: 2524009
references.citation: BMC Pharmacol. 2004 Jul 16;4:11
references.pmid: 15257759
references.citation: Immunol Rev. 2007 Feb;215:59-76
references.pmid: 17291279
references.citation: J Rheumatol. 2011 Jun;38(6):1123-9
references.pmid: 21406498
references.citation: Ann Rheum Dis. 2002 May;61(5):438-43
references.pmid: 11959768
references.citation: Ann Rheum Dis. 1990 Dec;49(12):980-2
references.pmid: 2270970
references.citation: Ann Rheum Dis. 1993 Dec;52(12):897
references.pmid: 8311545
references.citation: Semin Immunol. 2010 Aug;22(4):199-206
references.pmid: 20447835
references.citation: Br J Rheumatol. 1992 Aug;31(8):527-30
references.pmid: 1386549
references.citation: Alcohol Clin Exp Res. 1999 Sep;23(9):1457-61
references.pmid: 10512310
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):258-63
references.pmid: 17185416
references.citation: Br J Pharmacol. 2006 Feb;147(4):437-45
references.pmid: 16402039
references.citation: J Exp Med. 2003 Aug 4;198(3):391-7
references.pmid: 12900516
references.citation: Lancet. 2009 Feb 21;373(9664):659-72
references.pmid: 19157532
references.citation: Front Biosci. 1997 Feb 15;2:d61-77
references.pmid: 9159213
references.citation: BMJ. 2011 Feb 22;342:d671
references.pmid: 21343207
references.citation: J Immunol. 2007 Feb 1;178(3):1243-9
references.pmid: 17237368
references.citation: Biochem Pharmacol. 2010 Sep 15;80(6):838-45
references.pmid: 20470757
references.citation: Blood. 2001 Sep 1;98(5):1616-8
references.pmid: 11520816
references.citation: J Immunol. 2012 May 1;188(9):4349-59
references.pmid: 22450805
references.citation: Annu Rev Immunol. 2000;18:975-1026
references.pmid: 10837080
references.citation: Ann Rheum Dis. 2009 Feb;68(2):222-7
references.pmid: 18535114
references.citation: BMJ. 2012 Jul 10;345:e4230
references.pmid: 22782847
references.citation: J Leukoc Biol. 1993 Dec;54(6):534-44
references.pmid: 7504044
references.citation: J Exp Med. 1997 Nov 3;186(9):1407-18
references.pmid: 9348298